Filter
896
Text search:
MDR-TB
Featured
Recommendations
89
New Publications
246
Language
Document type
No document type
695
Studies & Reports
67
Guidelines
61
Manuals
20
Strategic & Response Plan
16
Fact sheets
15
Situation Updates
14
Training Material
6
Resource Platforms
1
Infographics
1
Countries / Regions
Western and Central Europe
63
Eastern Europe
47
India
36
Kenya
23
South Africa
23
Ukraine
17
Tanzania
16
Ethiopia
15
Nepal
15
Malawi
15
Myanmar / Burma
15
Bangladesh
14
Namibia
14
Uganda
12
Zambia
12
Rwanda
12
Latin America and the Carribbean
12
Asia
12
Cambodia
11
Liberia
9
Lesotho
9
South–East Asia Region
9
Russia
9
Nigeria
8
Ghana
7
Indonesia
7
Botswana
7
Sierra Leone
6
Mozambique
6
Philippines
5
Germany
5
Colombia
5
Tajikistan
5
Senegal
4
Zimbabwe
4
Global
4
Guinea
3
Congo, Democratic Republic of
3
Benin
3
Argentina
3
Peru
3
Eswatini/ Swaziland
3
Bhutan
3
Armenia
3
Timor Leste/ East Timor
3
Georgia
3
Burkina Faso
2
Pakistan
2
Central African Republic
2
Madagascar
2
Sri Lanka
2
Paraguay
2
Venezuela
2
Albania
2
Moldova
2
Vietnam
2
Cameroon
1
Somalia
1
South Sudan
1
Afghanistan
1
Gambia
1
El Salvador
1
Bolivia
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Africa
1
North Korea
1
Estonia
1
Kazakhstan
1
Turkmenistan
1
Maldives
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
318
Clinical Guidelines
86
Public Health
28
Capacity Building
8
Women & Child Health
8
Pharmacy & Technologies
7
Key Resources
6
Toolboxes
TB
492
HIV
76
AMR
36
Polio
20
Refugee
14
Pharmacy
10
Conflict
8
Ebola
7
Global Health Education
7
NTDs
6
Rapid Response
4
COVID-19
4
Caregiver
4
Health Financing Toolbox
3
Disability
2
Natural Hazards
2
Mental Health
2
NCDs
2
Specific Hazards
1
Planetary Health
1
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on
...
Accessed November 2017
Tuberculosis MDR-TB & XDR-TB The 2008 Report
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizatio
...
6th edition
For full course visit: https://drtbnetwork.org/training-course-MDR-TB
This course has been designed to take three days. It is composed of lectures, in-class readings, exercises, case discussions, a
...
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate
...
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO
...
The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regim
...
National Action Plan: Programmatic Management of Drug Resistance Tuberculosis, Tuberculosis Control Indonesia
Las recomendaciones contenidas en este módulo son un componente de las directrices unificadas de la OMS sobre la tuberculosis (TB) y están destinadas principalmente para el uso de los programas nacionales de control de la tuberculosis, los organismos de salud pública y otros interesados clave que
...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months
...
Tuberculosis (TB) is an infectious disease that usually affects the lungs, though it can affect any organ in the body. It can develop when bacteria spread through droplets in the air. TB can be fatal, but in many cases, TB is preventable and treatable. This report examines the human rights impact of
...
